MESENCHYMAL STROMAL CELLS IMPROVE DOPAMINERGIC GRAFT SURVIVAL AND REINNERVATION IN PARKINSON'S DISEASE ANIMAL MODEL IN A DOSE-DEPENDENT WAY

MESENCHYMAL STROMAL CELLS IMPROVE DOPAMINERGIC GRAFT SURVIVAL AND REINNERVATION IN PARKINSON'S DISEASE ANIMAL MODEL IN A DOSE-DEPENDENT WAY

Bibliographic Details
Main Authors:	Juan Parga, Jannette Rodríguez-Pallares, María García-Garrote, José Luis Labandeira-García
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	IBRO Neuroscience Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242123003639

Similar Items

Combined cell-based therapy strategies for the treatment of Parkinson’s disease: focus on mesenchymal stromal cells
by: Jannette Rodríguez-Pallares, et al.
Published: (2023-01-01)

Dopaminergic Reinnervation of the Globus Pallidus by Fetal Nigral Grafts in the Rodent Model of Parkinson's Disease
by: L. E. Bartlett, et al.
Published: (2005-02-01)

NRF2 Activation and Downstream Effects: Focus on Parkinson’s Disease and Brain Angiotensin
by: Juan A. Parga, et al.
Published: (2021-10-01)

DOPAMINE INCREASE ADULT NEUROGENESIS IN THE VENTRICULAR-SUBVENTRICULAR ZONE VIA DOPAMINE D3 RECEPTORS AND RECIPROCAL INTERACTIONS WITH ANGIOTENSIN TYPE 2 RECEPTOR.
by: Juan Parga, et al.
Published: (2023-10-01)

Data on the effect of Angiotensin II and 6-hydroxydopamine on reactive oxygen species production, antioxidant gene expression and viability of different neuronal cell lines
by: Juan A. Parga, et al.
Published: (2018-12-01)

Brain renin-angiotensin system and dopaminergic cell vulnerability
by: Jose L Labandeira-Garcia, et al.
Published: (2014-07-01)

Ectopic Dopaminergic Progenitor Cells from Transgenic Mice Survive and Functionally Reinnervate the Striatum Following Transplantation in a Rat Model of Parkinson's Disease
by: Christina Hackl, et al.
Published: (2010-09-01)

Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS
by: J. Rodriguez-Pallares, et al.
Published: (2008-07-01)

Effects of Antioxidant Pretreatment on the Survival of Embryonic Dopaminergic Neurons In Vitro and following Grafting in an Animal Model of Parkinson's Disease
by: R. M. Love, et al.
Published: (2002-10-01)

Noradrenergic and Cholinergic Reinnervation of Islet Grafts in Diabetic Rats
by: Harmina Houwing, et al.
Published: (1996-01-01)

Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson’s disease
by: Yi Zhao, et al.
Published: (2018-01-01)

PARKINSON’S DISEASE: ANIMAL MODELS AND DOPAMINERGIC CELL VULNERABILITY
by: Javier eBlesa, et al.
Published: (2014-12-01)

Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease
by: Eunju Shin, et al.
Published: (2012-09-01)

A Sequential Intrastriatal Dopaminergic Graft Strategy in the Rodent Model for Parkinson's Disease: Implications for Graft Survival and Targeting
by: K. A. Baker, et al.
Published: (2002-04-01)

Dopaminergic agonists in Parkinson's disease
by: A. Alonso Cánovas, et al.
Published: (2014-05-01)

Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease
by: Ezia Guatteo, et al.
Published: (2022-04-01)

Human Mesenchymal Stromal Cells Unveil an Unexpected Differentiation Potential toward the Dopaminergic Neuronal Lineage
by: Giulia Gaggi, et al.
Published: (2020-09-01)

Targeted Nipple Reinnervation in Gender-affirming Mastectomy Using Autologous Nerve Graft
by: Albert Y. Truong, MD, et al.
Published: (2023-09-01)

Progress in facial reinnervation
by: Hanshuo Zhu, et al.
Published: (2021-09-01)

Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease
by: Kilian Kelly, et al.
Published: (2021-10-01)

Mesenchymal stromal cell biotherapy for Parkinson’s disease premotor symptoms
by: Jinmei Sun, et al.
Published: (2023-10-01)

Effects of mesenchymal stem cell on dopaminergic neurons, motor and memory functions in animal models of Parkinson’s disease: a systematic review and meta-analysis
by: Jong Mi Park, et al.
Published: (2024-01-01)

Two-step grafting significantly enhances the survival of foetal dopaminergic transplants and induces graft-derived vascularisation in a 6-OHDA model of Parkinson's disease
by: Fabian Büchele, et al.
Published: (2014-08-01)

Striatal astrocytes engulf dopaminergic debris in Parkinson's disease: A study in an animal model.
by: Ingrid Morales, et al.
Published: (2017-01-01)

In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease
by: Nicoletta Rizzi, et al.
Published: (2018-06-01)

Liposomal Formulations of Tacrolimus and Rapamycin Increase Graft Survival and Fiber Outgrowth of Dopaminergic Grafts
by: Aylin Y. Alemdar, et al.
Published: (2004-04-01)

Dopaminergic and non-dopaminergic mechanisms of non-motor symptoms of Parkinson disease
by: Titus Mihai Vasile, et al.
Published: (2012-12-01)

Treadmill training of rats after sciatic nerve graft does not alter accuracy of muscle reinnervation
by: Mohammed Barham, et al.
Published: (2023-01-01)

The Effects of Transforming Growth Factor-β2 on Dopaminergic Graft Survival
by: Shannon L. Macauley, et al.
Published: (2004-04-01)

Targeted Nipple Areola Complex Reinnervation in Gender-affirming Double Incision Mastectomy with Free Nipple Grafting
by: Lisa Gfrerer, MD, PhD, et al.
Published: (2022-04-01)

Corneal subbasal nerve plexus reinnervation and stromal cell morphology with different cap thicknesses in small incision lenticule extraction
by: Yanzheng Song, et al.
Published: (2024-04-01)

Peripheral Nerve Regeneration and Muscle Reinnervation
by: Tessa Gordon
Published: (2020-11-01)

Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?
by: Neil Dunavin, et al.
Published: (2017-07-01)

Adult human mesenchymal stromal cells and the treatment of graft versus host disease
by: Herrmann RP, et al.
Published: (2014-02-01)

Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers
by: Tik Shing Cheung, et al.
Published: (2020-06-01)

Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease
by: Juliana A. P. Godoy, et al.
Published: (2019-11-01)

NADPH-Oxidase, Rho-Kinase and Autophagy Mediate the (Pro)renin-Induced Pro-Inflammatory Microglial Response and Enhancement of Dopaminergic Neuron Death
by: Andrea Lopez-Lopez, et al.
Published: (2021-08-01)

Dosing Limitation for Intra-Renal Arterial Infusion of Mesenchymal Stromal Cells
by: Anders Munk, et al.
Published: (2022-07-01)

LONG-TERM DOPAMINERGIC THERAPY OF PARKINSON DISEASE
by: O. S. Levin
Published: (2017-05-01)

Parkinson’s disease, dopaminergic drugs and the plant world
by: Peter Kempster, et al.
Published: (2022-09-01)